76000 drugs samples examined in 2018-19, 2500 substandard: Govt

Image
Press Trust of India New Delhi
Last Updated : Jul 16 2019 | 8:35 PM IST

Of the 76,101 drug samples examined in the country last fiscal, over 2,500 did not meet the prescribed quality standards, while more than 200 were found to be spurious, the government told the Rajya Sabha Tuesday.

Answering a query in the Upper House, Minister of State for Health Ashwini Kumar Choubey said the figures were provided by the drugs controllers of various states and Union Territories.

He said that of the 76,101 medicine samples tested in 2018-19, 2,549 were found to be substandard and 205 were adulterated.

The minister said the government is committed to ensuring that the quality, safety and efficacy of drugs are not compromised.

Asked about the steps being taken in this regard, he said the government has put in place several measures including "strengthening of legal provisions, conducting workshops and training programmes for manufacturers and regulatory officials and measures such as risk based inspections."

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 16 2019 | 8:35 PM IST

Next Story